Showing results (211-220 of 227) with videos related to

Sort By:
Pageof 23
The Lancet. Oncology|December 8, 2018
Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trialGiuseppe Lombardi, Gian Luca De Salvo, Alba Ariela Brandes, et al.
The Lancet. Oncology|June 9, 2017
European Association for Neuro-Oncology (EANO) guidelines for palliative care in adults with gliomaAndrea Pace, Linda Dirven, Johan A F Koekkoek, et al.
Biosensors & Bioelectronics|February 7, 2023
AstroBio-CubeSat: A lab-in-space for chemiluminescence-based astrobiology experimentsDonato Calabria, Ilaria Trozzi, Elisa Lazzarini, et al.
American Journal of Clinical Oncology|May 22, 2018
Single-agent Bevacizumab in Recurrent Glioblastoma After Second-line Chemotherapy With Fotemustine: The Experience of the Italian Association of Neuro-OncologyFrancesco Pasqualetti, Andrea Pace, Alessandra Gonnelli, et al.
Neurology|June 3, 2021
Prospective Evaluation of Health Care Provider and Patient Assessments in Chemotherapy-Induced Peripheral NeurotoxicityPaola Alberti, Davide P Bernasconi, David R Cornblath, et al.
Neuro-Oncology Practice|December 14, 2020
Determining medical decision-making capacity in brain tumor patients: why and how?Andrea Pace, Johan A F Koekkoek, Martin J van den Bent, et al.
Journal of the Peripheral Nervous System : JPNS|January 24, 2019
Patients' and physicians' interpretation of chemotherapy-induced peripheral neurotoxicityGuido Cavaletti, David R Cornblath, Ingemar S J Merkies, et al.
Journal of Neurosurgical Sciences|April 30, 2020
Italian consensus and recommendations on diagnosis and treatment of low-grade gliomas. An intersociety (SINch/AINO/SIN) documentRoberta Rudà, Filippo F Angileri, Tamara Ius, et al.
Pageof 23